Biomarkers Require Refining in Lung Cancer Paradigm - OncLive
Biomarkers Require Refining in Lung Cancer Paradigm OncLive
Hossein Borghaei, DO, discusses pivotal and ongoing trials driven by biomarkers in lung cancer.
Hossein Borghaei, DO, discusses pivotal and ongoing trials driven by biomarkers in lung cancer.
Comments
Post a Comment